Israeli Stocks: Bezeq, Clal Biotechnology, Enlight, Golf, Ormat

Israel’s TA-25 Index advanced 0.9 percent to 1,335.14 at the 4:30 p.m. close in Tel Aviv. Investors traded about 1.84 billion shekels ($519 million) in shares and convertible securities.

The following stocks rose or fell today. Symbols are in parentheses.

Bezeq Israeli Telecommunication Corp. (BEZQ IT) rose the most since Dec. 20, gaining 1.6 percent to 10.62 shekels. The The country’s largest communications company may sell more than 1 billion shekels ($281 million) of bonds to help pay a planned dividend of 3 billion shekels, TheMarker reported. Bezeq spokesman Guy Hadass declined to comment on the report.

Clal Biotechnology Industries Ltd. (CBI IT) increased the most since Jan. 3, adding 2.5 percent to 19.93 shekels. The company’s D-Pharm Ltd. unit has submitted a draft prospectus to raise funds over the next 12 months to complete Phase III tests, Clal said in a statement to the Tel Aviv Stock Exchange.

Enlight Renewable Energy Ltd. (ENLT IT) climbed the most since Nov. 28, adding 5.3 percent to 0.579 shekels. The developer of photovoltaic systems said it won two tenders to build 13 to 16 rooftop solar systems in Israel.

Golf & Co. Ltd. (GOLF IT) rose the most in almost two months, advancing 2.8 percent to 22.96 shekels. The Israeli retailer said it will pay 50 million shekels as dividend.

Ormat Industries Ltd. (ORMT IT) increased the most in almost a month, gaining 2.3 percent to 30.80 shekels. The builder of geothermal plants and its U.S. unit, Ormat Technologies Inc., were raised to “buy” from “market perform” at Clal Finance. Ormat Industries’ share-price estimate was set at 38 shekels and Ormat Technologies’ was raised to $42 from $34.

To contact the reporters on this story: Ronit Goodman in Tel Aviv at rgoodman9@bloomberg.net;

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.